Cyclosporine and 6-mercaptopurine in pediatric inflammatory bowel disease

Gastroenterol Nurs. 1994 Feb;16(4):169-75. doi: 10.1097/00001610-199402000-00007.

Abstract

After failure of medical therapy, children with refractory inflammatory bowel disease may require surgical intervention. In this article the authors describe one child in whom, after traditional therapies for refractory ulcerative colitis failed, full remission of the disease occurred after the addition of 6-mercaptopurine and cyclosporine A to her medical regimen. 6-Mercaptopurine has been used with increasing frequency in refractory inflammatory bowel disease; the use of cyclosporine A for this condition is still under investigation.

Publication types

  • Case Reports

MeSH terms

  • Child
  • Colitis, Ulcerative / drug therapy*
  • Combined Modality Therapy
  • Cyclosporine / administration & dosage*
  • Drug Therapy, Combination
  • Female
  • Humans
  • Inflammatory Bowel Diseases / drug therapy*
  • Mercaptopurine / administration & dosage*
  • Methylprednisolone / administration & dosage
  • Parenteral Nutrition, Total
  • Sulfasalazine / administration & dosage

Substances

  • Sulfasalazine
  • Cyclosporine
  • Mercaptopurine
  • Methylprednisolone